Bristol-Myers Squibb
BMY
#170
Rank
HK$981.08 B
Marketcap
HK$481.76
Share price
0.57%
Change (1 day)
9.66%
Change (1 year)

Revenue for Bristol-Myers Squibb (BMY)

Revenue in 2024: HK$374.97 Billion

According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM ) is HK$375.65 Billion. In 2024 the company made a revenue of HK$374.97 Billion an increase over the revenue in the year 2023 that were of HK$351.49 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bristol-Myers Squibb from 1996 to 2024

Annual revenue

Year Revenue Change
2024HK$374.97 B6.68%
2023HK$351.49 B-2.54%
2022HK$360.65 B-0.29%
2021HK$361.68 B9.73%
2020HK$329.60 B61.87%
2019HK$203.61 B15.25%
2018HK$176.67 B8.84%
2017HK$162.32 B7.75%
2016HK$150.64 B17.37%
2015HK$128.35 B4.21%
2014HK$123.16 B-3.06%
2013HK$127.05 B-6.98%
2012HK$136.58 B-17.22%
2011HK$165.00 B8.82%
2010HK$151.62 B17.12%
2009HK$129.46 B-18.66%
2008HK$159.16 B11.65%
2007HK$142.55 B2.32%
2006HK$139.32 B-6.44%
2005HK$148.91 B9.1%
2004HK$136.50 B-16.23%
2003HK$162.95 B15.32%
2002HK$141.30 B-5.52%
2001HK$149.55 B0.54%
2000HK$148.75 B-1.16%
1999HK$150.49 B6.24%
1998HK$141.65 B9.45%
1997HK$129.42 B11.07%
1996HK$116.52 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
HK$720.66 B 91.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$443.23 B 17.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$491.03 B 30.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$466.45 B 24.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$464.70 B 23.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$281.31 B-25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$371.67 B-1.06%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$78.72 B-79.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$502.36 B 33.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$454.59 B 21.01%๐Ÿ‡ฌ๐Ÿ‡ง UK